5'-3' exoribonuclease 2

From WikiMD's Wellness Encyclopedia

5'-3' exoribonuclease 2 is an enzyme that in humans is encoded by the EXOSC10 gene. This enzyme is a component of the RNA exosome complex, which is involved in the degradation and processing of RNA molecules. The 5'-3' exoribonuclease 2 plays a crucial role in RNA metabolism and is essential for various cellular processes, including RNA processing, RNA turnover, and the regulation of gene expression.

Function[edit | edit source]

The primary function of 5'-3' exoribonuclease 2 is to degrade RNA molecules from the 5' end towards the 3' end. This activity is vital for the maintenance of RNA quality within the cell by removing defective RNA molecules and processing certain RNA species. The enzyme participates in the degradation of messenger RNA (mRNA), ribosomal RNA (rRNA), and other RNA molecules, thereby regulating their levels within the cell. It is also involved in the maturation of various RNA species, playing a role in the generation of functional RNA molecules necessary for protein synthesis and other cellular functions.

Structure[edit | edit source]

The 5'-3' exoribonuclease 2 is a part of the larger RNA exosome complex, which consists of multiple subunits. The EXOSC10 gene encodes for one of the core components of this complex. The structure of the RNA exosome complex, including 5'-3' exoribonuclease 2, has been elucidated through various techniques such as X-ray crystallography and cryo-electron microscopy. These studies have revealed that the complex has a ring-like structure, with the 5'-3' exoribonuclease 2 positioned to interact with RNA substrates for efficient degradation and processing.

Clinical Significance[edit | edit source]

Mutations in the EXOSC10 gene, which encodes the 5'-3' exoribonuclease 2, have been associated with various human diseases. These include Pontocerebellar hypoplasia, a condition characterized by the underdevelopment of the cerebellum and brainstem, leading to severe neurological impairments. The enzyme's role in RNA processing and turnover suggests that disruptions in its function can have widespread effects on cellular metabolism, potentially leading to disease.

Research[edit | edit source]

Ongoing research is focused on understanding the detailed mechanisms by which 5'-3' exoribonuclease 2 and the RNA exosome complex regulate RNA metabolism. Studies are also exploring the potential therapeutic applications of modulating this enzyme's activity in diseases associated with RNA dysregulation, such as cancer and neurodegenerative disorders.

See Also[edit | edit source]

References[edit | edit source]


External Links[edit | edit source]


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD